Clinical Trial

Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis

Name: Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis — clinical trial record (NCT07400965)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a randomized, double-masked, placebo-controlled, dose-ranging, parallel-group, multi-center study designed to evaluate the safety and efficacy of GLK-321 in patients with Demodex blepharitis.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-02-03.

Trial Details

NCT Number	NCT07400965
Lead Sponsor	Glaukos Corporation
Conditions	Demodex Blepharitis
Enrollment	250 participants
Start Date	2025-12-05
Primary Completion	2026-09 (estimated)
Study Completion	2026-11 (estimated)
Updated on ClinicalTrials.gov	2026-02-27